• / Free eNewsletters & Magazine
  • / My Account
Home>Drug Companies

Drug Companies

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Research and Markets: Global Antiviral Therapeutics Report 2014 (Updated) - Technologies, Markets and Companies Analysis to 2023

    Research and Markets: Global Antiviral Therapeutics Report 2014 (Updated) - Technologies, Markets and Companies Analysis to 2023

  2. Research and Markets: The New Trends of Global Biomanufacturing Outsourcing

    Research and Markets: The New Trends of Global Biomanufacturing Outsourcing

  3. Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board

    Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board

  4. Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market

    Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market

  5. FDA Grants Tentative Approval for Lilly and Boehringer Ingelheim's Basaglar™ (insulin glargine injection)

    FDA Grants Tentative Approval for Lilly and Boehringer Ingelheim's Basaglar™ (insulin glargine injection)

  6. McKesson Corporation to Present at the 2014 Morgan Stanley Global Healthcare Conference

    McKesson Corporation to Present at the 2014 Morgan Stanley Global Healthcare Conference

  7. FDA Approves Genzyme’s Cerdelga™ (eliglustat) Capsules

    FDA Approves Genzyme’s Cerdelga™ (eliglustat) Capsules

  8. Half Year Report for the Six Months Ended 30 June 2014

    Half Year Report for the Six Months Ended 30 June 2014

  9. Research and Markets: Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Updated 2014 Report

    Research and Markets: Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Updated 2014 Report

  10. BioMed Realty Breaks Ground On New 122,000 Square Foot State-Of-The-Art Laboratory And Office Building Creating New Life Science Hub In Seattle

    BioMed Realty Breaks Ground On New 122,000 Square Foot State-Of-The-Art Laboratory And Office Building Creating New Life Science Hub In Seattle

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.